Circulating prostate cells found in men with benign prostate disease are P504S negative: Clinical implications

Journal of Oncology

Volumn , Issue , 2013, Pages

  Murray, Nigel P ^a,b,c   Reyes, Eduardo ^a,d   Badínez, Leonardo ^e   Orellana, Nelson ^a   Fuentealba, Cynthia ^a   Olivares, Ruben ^a   Porcell, José ^a   Dueñas, Ricardo ^a  

^a Department of Oral and Maxillofacial Surgery   (Chile)

^b Instituto de Bio Oncología   (Chile)

^c UNIVERSITY OF CHILE   (Chile)

^d UNIVERSIDAD DIEGO PORTALES   (Chile)

^e Centro Oncológico Fundación Arturo López Pérez   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

P504S PROTEIN; PROSTATE SPECIFIC ANTIGEN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CHRONIC PROSTATITIS; CIRCULATING TUMOR CELL; DIGITAL RECTAL EXAMINATION; FALSE POSITIVE RESULT; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PROSTATE BIOPSY; PROSTATE CANCER; PROTEIN EXPRESSION;

EID: 84877288214     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2013/165014     Document Type: Article

References (17)

1. Ashworth T. R., A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Medical Journal of Australia 1869 14 146 149
2. Allard W. J., Matera J., Miller M. C., Repollet M., Connelly M. C., Rao C., Tibbe A. G. J., Uhr J. W., Terstappen L. W. M. M., Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clinical Cancer Research 2004 10 20 6897 6904 2-s2.0-6044259206 10.1158/1078-0432.CCR-04-0378 (Pubitemid 39383039)
3. Pantel K., Denéve E., Nocca D., Circulating epitelial cells in patients with benign colon diseases. Clinical Chemistry 2012 58 5 936 940 10.1373/clinchem.2011.175570
4. Mikolajczyk S. D., Millar L. S., Tsinberg P., Coutts S. M., Zomorrodi M., Pham T., Bischoff F. Z., Pircher T. J., Detection of EpCAM-negative and cytokeratin-negative circulating tumor cells in peripheral blood. Journal of Oncology 2011 2011 10 2-s2.0-79959263061 10.1155/2011/252361 252361
5. Zhou M., Chinnaiyan A. M., Kleer C. G., Lucas P. C., Rubin M. A., Alpha-methylacyl-CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions. American Journal of Surgical Pathology 2002 26 7 926 931 2-s2.0-0036306325 10.1097/00000478-200207000-00012 (Pubitemid 34747646)
6. Beach R., Gown A. M., De Peralta-Venturina M. N., Folpe A. L., Yaziji H., Salles P. G., Grignon D. J., Fanger G. R., Amin M. B., P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies. American Journal of Surgical Pathology 2002 26 12 1588 1596 2-s2.0-0036891945 10.1097/00000478-200212000-00006 (Pubitemid 35387221)
7. Murray N. P., Calaf G. M., Badinez L., Dueñas R., Badinez O., Orellana N., Reyes E., Fuentealba C., P504S expressing prostate cells as a marker for prostate cancer. Oncology Reports 2010 24 3 689 692
8. Murray N. P., Reyes E., Tapia P., Diagnostic performance of malignant prostate cells detected in blood for early detection of prostate cancer: comparison to prostatic biopsy. Archivos Españoles de Urología 2011 64 10 961 971
9. Ouzzane A., Coloby P., Mignard J. P., Allegre J. P., Soulie M., Rebillard X., Salomon L., Villers A., Guidelines for prostatic biopsies best practice. Progres en Urologie 2011 21 1 18 28 2-s2.0-78650543845 10.1016/j.purol.2010.07. 001
10. Borgen E., Naume B., Nesland J. M., Kvalheim G., Beiske K., Fodstad O., Diel I., Solomayer E. F., Theocharous P., Coombes R. C., Smith B. M., Wunder E., Marolleau J. P., Garcia J., Pantel K., Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells: the European ISHAGE working group for Standardization of Tumor Cell Detection. Cytotherapy 1999 1 5 377 388 2-s2.0-21544473185
11. Rubin M. A., Zhou M., Dhanasekaran S. M., Varambally S., Barrette T. R., Sanda M. G., Pienta K. J., Ghosh D., Chinnaiyan A. M., Alpha-methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. Journal of the American Medical Association 2002 287 13 1662 1670 2-s2.0-0037012476 (Pubitemid 34289218)
12. Coussens L. M., Werb Z., Inflammation and cancer. Nature 2002 420 6917 860 867 2-s2.0-0037180757 10.1038/nature01322 (Pubitemid 36019639)
13. Davis J. W., Nakanishi H., Kumar V. S., Bhadkamkar V. A., McCormack R., Fritsche H. A., Handy B., Gornet T., Babaian R. J., Circulating tumor cells in peripheral blood samples from patients with increased serum prostate specific antigen: initial results in early prostate cancer. Journal of Urology 2008 179 6 2187 2191 2-s2.0-43049087002 10.1016/j.juro.2008.01.102
14. Eschwège P., Moutereau S., Droupy S., Douard R., Gala J. L., Benoit G., Conti M., Manivet P., Loric S., Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study. British Journal of Cancer 2009 100 4 608 610 2-s2.0-60349094661 10.1038/sj.bjc.6604912
15. Stott S. L., Lee R. J., Nagrath S., Isolation and characterization of cir culating tumor cell from patients with localized and metastatic prostate cancer. Science Translational Medicine 2010 2 25 25 10.1126/scitranslmed.3000403
16. Thiounn N., Saporta F., Flam T. A., Pages F., Zerbib M., Vieillefond A., Martin E., Debré B., Chevillard S., Positive prostate-specific antigen circulating cells detected by reverse transcriptase-polymerase chain reaction does not imply the presence of prostatic micrometastases. Urology 1997 50 2 245 250 2-s2.0-0030789262 10.1016/S0090-4295(97)00272-0 (Pubitemid 27339941)
17. Coumans F. A. W., Doggen C. J. M., Attard G., de Bono J. S., Terstappen L. W. M. M., All circulating EpCAM+CK+CD45-objects predict overall survival in castration-resistant prostate cancer. Annals of Oncology 2010 21 9 1851 1857 2-s2.0-77955082633 10.1093/annonc/mdq030